Wellnex Life Limited reported unaudited revenue results for the first half of fiscal year of 2022. Revenue for the first half of FY22 was up18.5% up on the prior corresponding period (PCP) to $8.84 million (unaudited), with an additional $1.6 million in Purchase Orders received to be invoiced in the second half of 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 AUD | 0.00% |
|
-3.85% | +8.70% |
06-05 | Wellnex Life to Launch Medicinal Cannabis Product Range; Shares Fall 3% | MT |
05-24 | Wellnex Life Partners Chemist Warehouse to Reintroduce Pain Away in New Zealand | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.70% | 21.32M | |
+30.33% | 30.21B | |
+9.19% | 6.1B | |
-16.69% | 4.13B | |
+1.99% | 3.73B | |
-8.01% | 1.71B | |
-2.61% | 1.61B | |
-16.76% | 1.22B | |
-21.84% | 1.07B | |
-33.86% | 844M |
- Stock Market
- Equities
- WNX Stock
- News Wellnex Life Limited
- Wellnex Life Limited Reports Unaudited Revenue Results for the First Half of Fiscal Year of 2022